02.08.2012Swiss India Biotechnology ForumYou are hereEventsLife science events Swiss India Biotechnology Forum
India is ranked as the world's 4th largest pharmaceutical market in terms of volume and the 13th largest in terms of value. Switzerland is the home of two of the world's top ten pharmaceutical companies and therefore is regarded as the pharma capital of the world. As a result there are immense untapped resources to explore for fruitful collaborations.
This event will focus on the emerging business models in the industry, both from Swiss and Indian perspectives.
The topics of discussion will include:
- Challenges of manufacturing API in India
- Market Access in India
- Clinical trials in India
- New technologies from Swiss R&D
- New regulatory challenges